Physician profile
Wendy E Mallory
NPI 1255824108
$1,929.30
in general payments reported to CMS, 2019-2025
23 companies · $452 in 2025
The $452 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $450 · 2022: $376 · 2023: $230 · 2024: $422 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,073 · Education: $30.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,073.29 |
| Education | $30.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $778.52 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $134.67 | 2021-2024 | Imfinzi |
| Astellas Pharma US INC | $120.15 | 2025 | Vyloy |
| E.R. Squibb & Sons, L.L.C. | $116.02 | 2025 | Reblozyl |
| Merck Sharp & Dohme LLC | $111.74 | 2022-2024 | Keytruda |
| Novo Nordisk INC | $105.47 | 2021-2023 | Wegovy |
| Novartis Pharmaceuticals Corporation | $90.27 | 2021-2025 | |
| Caris Mpi, INC. | $71.35 | 2025 | Mi Cancer Seek |
| Adaptive Biotechnologies Corporation | $66.44 | 2024-2025 | Clonoseq |
| Novocure INC. | $65.34 | 2024-2025 | Optune Lua (Novottf-200t), Optune |
| Janssen Pharmaceuticals, INC | $48.91 | 2021-2022 | |
| Pfizer INC. | $30.65 | 2025 | |
| Philips North America LLC | $21.81 | 2024 | (Ck6) Holter |
| Abbott Laboratories | $20.14 | 2021 | |
| Corium, LLC | $19.91 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $19.07 | 2022 | |
| Tempus Ai, INC | $17.86 | 2024 | |
| Gilead Sciences, INC. | $16.67 | 2021 | |
| Almatica Pharma LLC | $16.30 | 2022 | |
| Medtronic, INC. | $16.14 | 2022 | |
| Lilly USA, LLC | $14.77 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14.09 | 2022 | |
| Glaxosmithkline, LLC. | $13.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendy Mallory listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.